| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |